In cells into which FLT3-ITD is introduced by a conventional method (e.g., using a viral vector), the ectopic FLT3-ITD gene would be overexpressed, potentially resulting in a phenotype distinct from that of actual patient leukemia cells, which typically may not overexpress the mutant gene. This evidence concerns the gene FLT3 and leukemia.